Dr. Zioncheck currently serves as Senior Director in the Business Development Group at Genentech. His team is responsible for in-licensing new therapeutics,technology, and intellectual property in the areas of Ophthalmology, Neuroscience, Cardiovascular and Metabolic Disease. Dr. Zioncheck joined Genentech as a Postdoctoral Fellow in 1988.
He was subsequently hired as a Genentech Scientist in 1991. He was then promoted into various roles with increasing responsibility including Sr. Scientist, Development Sciences Director, and Project Team Leader. During the course of his career he has madenumerous drug development contributions, co-authored over 30 scientific papers, has been awarded six patents, and received 18 recognition awards for variouscorporate accomplishments. In 2001, he waselected Chair for the American Association of Pharmaceutical Scientists (AAPS) Biotech Section and he served as co-chair for the first National AAPS Biotechnology meeting.
In 2002, he was appointed as Adjunct Professor in the Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, in Stockton CA. Dr. Thomas F. Zioncheck earned his BS degree in Chemistry from the State University of NewYork at Oneonta and his Ph.D. in Biochemistry from Purdue University.